Seroepidemiological study of influenza A (H1N1) pdm09 virus following the 2009-2010 wave in Shandong Province, China

Scandinavian Journal of Infectious Diseases

Volumn 45, Issue 7, 2013, Pages 552-556

  Liu, Ti ^a   Li, Zhong ^a   Song, Shaoxia ^a   Zhang, Shengyang ^a   Wang, Yulu ^a   Wang, Lanying ^a   Xu, Aiqiang ^a   Wang, Xianjun ^a   Bi, Zhenqiang ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

China; Influenza A (H1N1) pdm09; Seropositive rate

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CHILD; CHINA; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FAMILY COUNSELING; FEMALE; GENDER; GROUPS BY AGE; HEALTH SURVEY; HEMAGGLUTINATION INHIBITION; HUMAN; INFANT; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RISK FACTOR; RURAL AREA; SCHOOL CHILD; SEROEPIDEMIOLOGY; SEROLOGY; SEROPREVALENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84879103947     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2013.793818     Document Type: Article

References (25)

1. Center for Disease Control and Prevention. S wine infl uenza A (H1N1) infection in two children-Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 400-2.
2. World Health Organization. World now at the start of 2009 infl uenza pandemic: statement to the press by WHO Director-General Dr Margaret Chan. Geneva: WHO; 2009. Available at: http://www.who.int/mediacentre/news/statements/ 2009/h1n1-pandemic-phase6-20090611/en/index.html (accessed 28 June 2011).
3. Wu JT, Ma ES, Lee CK, Chu DK, Ho PL, Shen A L, et al. T he infection attack rate and severity of 2009 pandemic H1N1 infl uenza in Hong Kong. Clin Infect Dis 2010; 51: 1184-91.
4. Lin Y, Liu T, Wang S, R en Y, Li Z, Wang X. S eroepidemiologic survey for antibody of the inapparent infection of pandemic infl uenza A(H1N1) in Shandong Province (In Chinese). Prev Med Trib 2010; 16: 293-4.
5. Liu T, Lin Y, Zhang S, Wang S, R en Y, Li Z, et al. A nalysis on serum antibody level to pandemic infl uenza A ( H1N1) virus in some population in Shandong Province (In Chinese). Disease Surveillance 2011; 26: 136-8.
6. Xu C, B ai T, I uliano AD, Wang M, Y ang L, W en L, et a l. T he seroprevalence of pandemic infl uenza H1N1 (2009) virus in China. PLoS One 2010; 6: e17919.
7. Achonu C, R osella L, G ubbay JB, D eeks S, R ebbapragada A, Mazzulli T, et al. Seroprevalence of pandemic infl uenza H1N1 in Ontario from January 2009-May 2010. PLoS One 2011; 6: e26427.
8. Tian LL, S hi WX, Y ing D, P ang XH, P eng Y, F ang H, et al. Serologic survey of pandemic infl uenza A (H1N1 2009) in Beijing, China. Preventive Medicine 2011; 52: 71-4.
9. Š ubelj V, P rosenc K, S o an M. S eroprevalence study of antibodies against infl uenza A(H1N1) 2009 virus after the second pandemic wave in Slovenia. Wien Klin Wochenschr 2012; 124: 177-80.
10. Zhang X, H e J, Li L, Z hu X, K e C, N i H, et al. S erologic survey of the pandemic H1N1 2009 virus in Guangdong Province, China: a cross sectional study. PLoS One 2010; 6: e23034.
11. Cox CM, G oodin K, F isher E, D awood FS, H amilton JJ, Leparc GF, et al. Prevalence of 2009 pandemic infl uenza A (H1N1) virus antibodies, Tampa Bay Florida: November-December, 2009. PLoS One 2011; 6: e29301.
12. Maltezou H C, D rancourt M. N osocomiaLinfl uenza in children. J Hosp Infect 2003; 55: 83-91.
13. Cauchemez S, D onnelly C A, R eed C, G hani AC, Fraser C, Kent CK, et al. Household transmission of 2009 pandemic infl uenza A (H1N1) virus in the United States. N Engl J Med 2009; 361: 2619-27.
14. Centers for Disease Control and Prevention (CDC). Swine-origin infl uenza A (H1N1) virus infections in a school-New York City, April 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 470-2.
15. National Center for Immunization and R espiratory Diseases, CDC. Use of infl uenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009; 58: 1-8.
16. Miller E, H oschler K, H ardelid P, S tanford E, A ndrews N, Zambon M. Incidence of 2009 pandemic infl uenza A H1N1 infection in England: a cross sectional serological study. Lancet 2010; 375: 1100-8.
17. Maltezou HC, K aterelos P, M avrouli M, L ourida A, Routsias JG, Spanakis N, et al. Seroepidemiological study of pandemic infl uenza H1N1 following the 2009-2010 wave in Greece. Vaccine 2011; 29: 6664-9.
18. France A M, J ackson M, S chrag S, L ynch M, Z immerman C, Biggerstaff M, et al. Household transmission of 2009 infl uenza A (H1N1) virus after a school-based outbreak in New York City, April-May 2009. J Infect Dis 2010; 201: 984-92.
19. Miller MA, V iboud C, B alinska M, S imonsen L. T he signature features of infl uenza pandemics-implications for policy. N Engl J Med 2009; 360: 2595-8.
20. Chowell G, B ettencourt LM, J ohnson N, A lonso W J, Viboud C. The 1918-1919 infl uenza pandemic in England and Wales: spatial patterns in transmissibility and mortality impact. Proc Biol Sci 2008; 275: 501-9.
21. Onozuka D, H agihara A. S patial and temporal dynamics of infl uenza outbreaks. Epidemiology 2008; 19: 824-8.
22. Z hou Y, N g D M, S eto W H, I p D K, K wok H K, M a E S, et a l. Seroprevalence of antibody to pandemic infl uenza A (H1N1) 2009 among healthcare workers after the fi rst wave in Hong Kong. J Hosp Infect 2011; 78: 308-11.
23. Maltezou HC, D edoukou X, P atrinos S, M aragos A, Poufta S, Gargalianos P, et al. Determinants of intention to get vaccinated against novel (pandemic) infl uenza A H1N1 among health-care workers in a nationwide survey. J Infect 2010; 61: 252-8.
24. Zhu FC, Wang H, F ang HH, Y ang JG, Lin XJ, Liang XF, et al. A noveLinfl uenza A (H1N1) vaccine in various age groups. N Engl J Med 2009; 361: 2414-23.
25. Liang XF, Wang HQ, Wang JZ, F ang HH, W u J, Z hu FC, et al. Safety and immunogenicity of 2009 pandemic infl uenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2010; 375: 56-66.